• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSPHERE MEDICAL S.A.; EMBOSPHERE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSPHERE MEDICAL S.A.; EMBOSPHERE Back to Search Results
Catalog Number S020GH
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Necrosis (1971); Urinary Retention (2119); Bladder Dysfunction (4881)
Date of Event 02/26/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event was identified during internal quality system activities involving retrospective review of literature sources.Upon review, the manufacturer determined the event meets applicable medical device reporting criteria and is submitting this report to ensure completeness of complaint and mdr documentation.This submission does not represent new information regarding device performance or a change in the known risk profile of the device.The suspect device was not returned for evaluation.The complaint could not be confirmed.The root cause could not be determined.A review of the device history and complaint database could not be performed since the lot number was not provided.Nonconformances of this nature are monitored by the operation team.This complaint will be used to trend for similar complaints.If additional information becomes available, a supplemental report will be submitted.
 
Event or Problem Description
Study: parikh, n., keshishian, e., manley, b., grass, g.D., torres-roca, j., boulware, d., feuerlein, s., pow-sang, j.M., bagla, s., yamoah, k., & bhatia, s.(2021).Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer.Journal of vascular and interventional radiology, 32(7), 1053-1061.Https://doi.Org/10.1016/j.Jvir.2021.03.534 was reviewed during internal quality system activities and describes 2 patients experiencing bladder spasm and 1 patient experiencing urinary retention successfully treated with alpha-blockers.One case resulted in penile meatal necrosis from nontarget embolization which met the criteria for sir grade c complication.This patient was successfully managed with supportive care and healed 6 weeks after pae.The patient was also able to successfully undergo radiation therapy without acute or chronic gu toxicity.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
EMBOSPHERE
Manufacturer (Section D)
BIOSPHERE MEDICAL S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR  95700
Manufacturer (Section G)
BIOSPHERE MEDICAL S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR   95700
Manufacturer Contact
marie-laure patucca
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france, 95700
FR   95700
MDR Report Key25813889
Report Number9615728-2026-00107
Device Sequence Number5964866
Product Code KRD
UDI-Device Identifier00884450402948
UDI-Public00884450402948
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
K181300
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Literature,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberS020GH
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/26/2024
Initial Report FDA Received Date07/14/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-